The global medical affairs outsourcing market size is evaluated at USD 2.08 billion in 2025 and is forecasted to hit around USD 3.89 billion by 2034, growing at a CAGR of 7.18% from 2025 to 2034. The North America market size was accounted at USD 710 million in 2024 and is expanding at a CAGR of 6.64% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. Medical Affairs Outsourcing Market, by Services Type
7.1.1. Medical Monitoring
7.1.1.1. Market Revenue and Forecast
7.1.2. Medical Writing & Publishing
7.1.2.1. Market Revenue and Forecast
7.1.3. Medical Information
7.1.3.1. Market Revenue and Forecast
7.1.4. Medical Science Liaisons
7.1.4.1. Market Revenue and Forecast
7.1.5. Others
7.1.5.1. Market Revenue and Forecast
8.1. Medical Affairs Outsourcing Market, by Industry
8.1.1. Medical Devices
8.1.1.1. Market Revenue and Forecast
8.1.2. Pharmaceutical
8.1.2.1. Market Revenue and Forecast
8.1.3. Biopharmaceutical
8.1.3.1. Market Revenue and Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Services
9.1.2. Market Revenue and Forecast, by Industry
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Services
9.1.3.2. Market Revenue and Forecast, by Industry
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Services
9.1.4.2. Market Revenue and Forecast, by Industry
9.2. Europe
9.2.1. Market Revenue and Forecast, by Services
9.2.2. Market Revenue and Forecast, by Industry
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Services
9.2.3.2. Market Revenue and Forecast, by Industry
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Services
9.2.4.2. Market Revenue and Forecast, by Industry
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Services
9.2.5.2. Market Revenue and Forecast, by Industry
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Services
9.2.6.2. Market Revenue and Forecast, by Industry
9.3. APAC
9.3.1. Market Revenue and Forecast, by Services
9.3.2. Market Revenue and Forecast, by Industry
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Services
9.3.3.2. Market Revenue and Forecast, by Industry
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Services
9.3.4.2. Market Revenue and Forecast, by Industry
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Services
9.3.5.2. Market Revenue and Forecast, by Industry
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Services
9.3.6.2. Market Revenue and Forecast, by Industry
9.4. MEA
9.4.1. Market Revenue and Forecast, by Services
9.4.2. Market Revenue and Forecast, by Industry
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Services
9.4.3.2. Market Revenue and Forecast, by Industry
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Services
9.4.4.2. Market Revenue and Forecast, by Industry
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Services
9.4.5.2. Market Revenue and Forecast, by Industry
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Services
9.4.6.2. Market Revenue and Forecast, by Industry
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Services
9.5.2. Market Revenue and Forecast, by Industry
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Services
9.5.3.2. Market Revenue and Forecast, by Industry
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Services
9.5.4.2. Market Revenue and Forecast, by Industry
10.1. ICON plc
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Wuxi Clinical Development, Inc
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Pharmaceutical Product Development, LLC
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Ashfield Healthcare Communications
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Indegene Inc.
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. IQVIA Holdings Inc
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. The Medical Affairs Company (TMAC)
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. SGS SA
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Syneos Health Inc
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. ZEINCRO Group
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
12.1. About Us
12.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample